Investment Rating - The report assigns a "Buy" rating to several companies in the pharmaceutical sector, indicating a potential upside of over 15% in the next 12 months [2][30]. Core Insights - The MSCI China Healthcare Index has increased by 74.0% since the beginning of 2025, outperforming the MSCI China Index, which rose by 37.3% [1]. - There is a recovery in domestic demand for innovative drug research and development, driven by a resurgence in capital market financing and an increase in the scale of innovative drug transactions abroad [1]. - The price for experimental monkeys, essential for innovative drug research, has risen from approximately 85,000 yuan in mid-2024 to about 90,000 yuan [1]. - The CXO industry is expected to see performance recovery in the second half of 2025 due to the impact of U.S. interest rate cuts [1]. Summary by Sections Industry Overview - The report anticipates that U.S.-China innovation cooperation will continue, despite differing opinions in the U.S. [4]. - The global pharmaceutical innovation pipeline is shifting from Western biotech firms to Chinese biotech companies [4]. - Major multinational pharmaceutical companies are investing significantly in U.S. facilities, which may mitigate the impact of proposed tariffs on innovative drugs [4]. Company Recommendations - The report recommends buying shares in the following companies: - 三生制药 (Sangfor) [2] - 巨子生物 (Giant Biotech) [2] - 药明合联 (WuXi AppTec) [2] - 固生堂 (Gushengtang) [2] - 中国生物制药 (China National Pharmaceutical) [2] - 信达生物 (Innovent Biologics) [2] Market Trends - The report highlights that the continuous rise in innovative drugs will primarily come from overseas partners pushing clinical pipelines that have been licensed [4]. - There is optimism regarding the valuation recovery opportunities in consumer healthcare [4].

Core Viewpoint - The performance of consumer-themed funds has improved after expanding and updating the definition of the consumer industry, despite the recent decline in the stock prices of heavily weighted consumer stocks [1][2]. Group 1: Consumer Fund Performance - Consumer-themed funds have shown a divergence in performance, with some actively managed equity consumer funds and passive consumer ETFs performing well, while traditional consumer stocks have faced significant downward pressure [1][2]. - The performance difference among consumer ETFs is largely attributed to how fund managers and indices define "consumption," with those including technology stocks seeing better returns [2][3]. Group 2: Inclusion of Technology Stocks - The inclusion of technology stocks in consumer industry indices has helped mitigate the impact of declines in traditional consumer stocks on related ETFs [3]. - Some consumer funds have strategically broadened their investment scope to include sectors like technology, semiconductors, and innovative pharmaceuticals, which has positively influenced their performance [4][5]. Group 3: Market Trends and Strategies - The current market consensus is shifting towards technology-driven investments, particularly in artificial intelligence, which is becoming a dominant theme in the investment landscape [6][7]. - Fund managers are increasingly focusing on technology characteristics while downplaying traditional consumer sectors, as consumer stocks are currently experiencing valuation compression [6][7]. Group 4: Fund Examples and Strategies - Specific funds, such as the Guorong Huagang Deep Consumption Fund, have achieved significant returns (58.56%) by expanding their definition of consumption to include high-growth sectors like AI and semiconductors [4]. - Other funds, like the Southern Consumption Upgrade Fund and Great Wall Consumption Value Fund, have also enhanced their performance by incorporating hard technology sectors into their portfolios [5].

Group 1 - Jihong Co., Ltd. expects a net profit attributable to shareholders of 209-222 million yuan for Q3 2025, representing a year-on-year increase of 55-65% [1] - The company's Q3 net profit is projected to be 91-104 million yuan, reflecting a growth of 47-68% [1] - The strong performance is driven by dual main businesses: cross-border e-commerce and packaging, benefiting from market expansion and brand development [1] Group 2 - The cross-border e-commerce segment leverages AI algorithms for precise customer targeting, creating a "goods find people" model distinct from traditional platforms [1] - The packaging business enhances operational efficiency through long-term partnerships with industry leaders and experiences a surge in demand due to the food-grade packaging needs from the food delivery sector [1] - The company is positioned for high-quality growth through digitalization and globalization strategies in both main business areas [1] Group 3 - The retail sector index reported a decline of 4.32% this week, underperforming the Shanghai Composite Index, which increased by 0.21% [7] - Among retail sub-sectors, the branded cosmetics segment experienced the smallest decline, while the watch and jewelry sector has been leading since the beginning of 2025 [7] - Notable stock performances include Ningbo Zhongbai (+24.7%), Jihong Co., Ltd. (+16.7%), and Xinghui Co., Ltd. (+10.5%) [7]

Core Viewpoint - The performance of consumer-themed funds has improved significantly after expanding and updating the definition of the consumer industry, despite the recent underperformance of heavily weighted consumer stocks in the public market [1][3]. Group 1: Performance of Consumer Funds - Consumer funds have shown a notable divergence in performance, with some actively managed consumer funds and passive consumer ETFs performing well, while traditional consumer stocks face significant adjustment pressure [1][3]. - The performance difference among consumer ETFs is largely attributed to how fund managers define "consumption," with some including technology stocks, which aligns with the current market consensus on technology as a core investment theme [3][4]. Group 2: Fund Manager Strategies - Fund managers have adopted strategies to expand the definition of consumption to include sectors like technology and pharmaceuticals, which has positively impacted fund performance [5][6]. - For instance, the Guorong Huagang Shen Consumer Fund achieved a return of 58.56% this year, largely due to its focus on technology-related stocks, reflecting a shift in the definition of "big consumption" [5]. Group 3: Market Trends and Insights - The current market consensus indicates a shift towards technology and artificial intelligence, with consumer spending showing signs of weakness, as evidenced by a 3.4% year-on-year growth in retail sales, slightly down from July [8]. - Long-term market dynamics are expected to be driven by the decline in risk-free interest rates and the transition of economic drivers, suggesting a potential for asset revaluation [9].

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The retail industry index decreased by 4.32% in the week of September 22-26, 2025, underperforming the Shanghai Composite Index, which increased by 0.21% [6][13] - The report highlights the strong performance of certain companies, such as Jihong Co., which is expected to achieve a net profit of 209-222 million yuan for Q3 2025, representing a year-on-year increase of 55-65% [4][26] - The report emphasizes the importance of emotional consumption themes and recommends focusing on high-quality companies in high-growth sectors [7][31] Summary by Sections Retail Market Review - The retail industry index closed at 2281.69 points, ranking 29th among 31 primary industries [6][13] - The brand cosmetics sector experienced the smallest decline of 1.31% during the week, while the watch and jewelry sector led with a year-to-date increase of 26.87% [18][20] Company Performance Highlights - Jihong Co. is expected to achieve a net profit of 209-222 million yuan for Q3 2025, driven by its dual business model of cross-border e-commerce and packaging [4][26] - Old Puhuang reported a revenue of 12.354 billion yuan for H1 2025, a year-on-year increase of 250.9%, with a net profit of 2.268 billion yuan, up 285.8% [36][37] - Chao Hong Ji achieved a revenue of 4.102 billion yuan in H1 2025, with a net profit increase of 44.3% [39] Investment Recommendations - Focus on high-quality companies in the gold and jewelry sector, such as Old Puhuang and Chao Hong Ji, which are expected to benefit from emotional consumption trends [7][31] - Emphasize the importance of offline retail companies that adapt to consumer trends, recommending companies like Yonghui Supermarket and Aiying Room [31][32] - Highlight the potential of domestic beauty brands, recommending companies like Mao Ge Ping and Po Lai Ya, which are positioned well in the high-end market [32][33]

Investment Rating - The industry investment rating is "Recommended" for the media sector, indicating an expected performance greater than 10% compared to the benchmark index [8]. Core Insights - The beauty market is expected to perform strongly during the 2024 Double Eleven shopping festival, with an online GMV of 126.7 billion yuan, reflecting a year-on-year growth of 17.42%. Tmall's GMV accounted for 50.1% of the market, with a 29.3% increase, while Douyin and JD.com followed with 26.7% and 11.7% market shares, respectively [4][5]. - Major e-commerce platforms are actively preparing for the 2025 Double Eleven, implementing various promotional strategies, including Tmall's "pre-sale + stock" and Douyin's significant marketing subsidies [4][6]. - Some beauty brands have already initiated promotional activities for Double Eleven, with notable discounts and subsidies to attract consumers [5][6]. Summary by Sections Industry Performance - The media sector has shown strong relative performance over the past year, with a 59.1% increase compared to the Shanghai and Shenzhen 300 index's 22.9% [1][2]. E-commerce Strategies - Tmall, Taobao, Douyin, and other platforms are launching innovative promotional strategies, including cash subsidies and interactive games, to enhance consumer engagement and drive sales [4][6]. Brand Promotions - Brands like Vino and Natural Hall are leading the charge with significant discounts and cash subsidies, indicating a competitive landscape as Double Eleven approaches [5][6]. Company Focus and Earnings Forecast - Specific companies such as 毛戈平 and 哔哩哔哩 are rated as "Buy," with projected earnings per share (EPS) growth and favorable price-to-earnings (PE) ratios for the coming years [8].

Core Insights - The global beauty industry is projected to exceed $677 billion by 2025, indicating strong growth, while the Chinese cosmetics market is undergoing significant structural changes, moving away from reliance on single blockbuster products or marketing gimmicks to a focus on genuine brand strength [1][2]. Market Performance - The Chinese cosmetics retail market is expected to maintain moderate growth in the first half of 2025, with retail sales reaching 2.291 billion yuan, a year-on-year increase of 2.9%, although this is below the overall retail growth rate of 5.0% [2][4]. - International beauty giants are facing pressure in the Chinese market, with L'Oréal leading with sales of 186.19 billion yuan, a 3% increase year-on-year, while Estée Lauder reported a 10.88% decline in net sales, marking its lowest sales in five years [4][6]. Domestic Brand Performance - Domestic brands are showing resilience, with the retail scale of the Chinese cosmetics market reaching 1.0738 trillion yuan in 2024, and domestic brands capturing 55.2% of the market share [6][8]. - The top ten domestic beauty companies reported a total revenue growth of 11.72% in the first half of 2025, with Proya, Shiseido, and Shanghai Jahwa leading the rankings [7][8]. Consumer Trends - The beauty market is witnessing a shift towards rational consumption, with consumers increasingly sensitive to price and favoring cost-effective products. The sales of beauty and skincare products reached 235.23 billion yuan in the first half of 2025, a 10.1% increase year-on-year [12][13]. - The anti-aging market is experiencing significant growth, with total sales reaching 65.49 billion yuan, a 30.3% increase year-on-year, and the demand for anti-aging products is expanding to younger demographics [13][14]. Brand Strategies - Brands are increasingly adopting multi-brand strategies to address diverse consumer needs, moving from a single product focus to a more comprehensive brand matrix [14][19]. - Investment in research and development is on the rise among leading domestic brands, with a focus on building technological barriers and enhancing product efficacy [15][16]. Marketing and Distribution - Douyin (TikTok) has solidified its position as a growth engine for the beauty industry, with daily views of beauty videos exceeding 2.5 billion, reflecting a shift towards more refined and systematic marketing strategies [17][18]. - The competition is evolving from a focus on single-channel strategies to an integrated approach that balances online and offline resources, emphasizing the importance of brand experience and customer loyalty [18][19].

Investment Rating - The report does not explicitly provide an investment rating for the beauty industry Core Insights - The beauty industry is experiencing a significant transformation driven by consumer preferences for high-quality, effective products and the integration of technology in skincare and cosmetics [4][6][10] Industry Trends - The high-end fragrance segment is witnessing robust growth, with the Chinese perfume market projected to reach 24.9 billion yuan by 2025 and exceed 33.9 billion yuan by 2028, reflecting a compound annual growth rate of 8% [4] - Domestic beauty brands are focusing on scientific innovation, market segmentation, and globalization to enhance competitiveness [6][7] - The integration of medical aesthetics and beauty is becoming a trend, with a projected annual growth rate of 10%-15% for the medical aesthetics market from 2024 to 2027 [10] - The beauty market is seeing a shift towards multi-brand strategies, with companies like Proya and Shiseido leading the way [6][11] Market Environment - Douyin e-commerce is revitalizing the perception of "Chinese good ingredients," enhancing consumer trust in domestic skincare products through educational campaigns [4] - The domestic beauty market grew by 3.1% in the first half of 2025, with significant performance disparities among companies [6] - The trend of "reverse export" to South Korea is emerging, as domestic brands seek to penetrate the Korean market through differentiated product offerings [6] Top Brand Dynamics - Proya leads the domestic beauty market with a revenue of 5.36 billion yuan, followed closely by other major players [11] - The report highlights the rise of makeup artist brands, with Unilever investing in Hung Vanngo Beauty, indicating a growing interest in professional makeup lines [13] - L'Oréal is accelerating its presence in the fragrance market with the launch of high-end perfumes, reflecting a strategic shift towards premium products [14] - The beauty industry is witnessing a surge in e-commerce, with platforms like JD.com reporting double-digit growth in beauty sales [18]

Major Events - China Railway (00390) recently won bids for 11 major projects, with a total contract value of approximately 50.215 billion yuan [1] - China Communications Technology (03969) secured four important projects in the railway market from July to August [1] - Chow Tai Fook (00659) plans to issue convertible bonds worth 2.218 billion HKD, converting approximately 10% of shares in First Journey Holdings (00697) [1] - Shanghai Pharmaceuticals (02607) transferred 40% equity of Shanghai Pharmaceuticals Group to Shanghai Shansi for about 6.7215 billion yuan [1] - Tianjin Port Development (03382) plans to invest 95.403 million yuan to acquire 5% equity in Eurasia International [1] - Tianjin Port Development (03382) intends to acquire 40% equity in Alliance International for 723 million yuan, increasing its stake to 100% [1] - First Journey Holdings (00697) received investment from Beijing Robotics Fund in Quan Zhi Bo, continuing to increase investment in the robotics industry [1] - Boleton (01333) signed a strategic cooperation agreement with Mingyang Mining to promote the electrification and intelligence of mining transportation [1] - China Biopharmaceutical (01177) completed the first patient enrollment in the Phase I clinical trial of LM-350 "CDH17 ADC" in Australia [1] - Xinjiang Xinmin Mining (03833) proposed to issue A-shares [1] - Jihong Co., Ltd. (02603) expects a year-on-year increase of 55%-65% in net profit attributable to shareholders for the first three quarters [1] Buybacks and Shareholding Changes - Tencent Holdings (00700) repurchased 844,000 shares for 550 million HKD on September 25 [1] - Midea Group (00300) repurchased 2.0 billion yuan worth of 2.7455 million A-shares on September 25 [1] - Anta Sports (02020) repurchased 99.819 million HKD worth of 106,500 shares on September 25 [1] - Guoquan (02517) plans to use up to 100 million HKD for further repurchase of H-shares [1] - Juzi Holding increased its stake by acquiring 1.15 million shares in Giant Bio (02367) [1] - Harmony Health, a shareholder of Goldwind Technology (02208), reduced its holdings by approximately 57.14185 million shares [1]

Core Insights - Juzi Holding Co., Ltd, the controlling shareholder of Juzi Bio, purchased a total of 1.15 million shares of the company on September 24 and 25, 2025, for approximately HKD 62.9 million, excluding commissions and other expenses [1] - Following this acquisition, Juzi Holding's shareholding increased to 583 million shares, representing 54.47% of the company's total issued shares [1] - Juzi Holding indicated the possibility of further increasing its stake depending on market conditions [1]